SPIA
AEON icon

Steward Partners Investment Advisory’s AEON Biopharma AEON Stock Holding History

Steward Partners Investment Advisory’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791 Hold
1,100
– – ﹤0.01% 4416
2026
Q1 		$1.08K Buy
1,100
+1,000
+1,000% +$1.12K ﹤0.01% 4174
2025
Q4 		$110 Hold
100
– – ﹤0.01% 4221
2025
Q3 		$81 Hold
100
– – ﹤0.01% 4197
2025
Q2 		$76 Hold
100
– – ﹤0.01% 4049
2025
Q1 		$58 Sell
100
-14
-12% -$100 ﹤0.01% 3957
2024
Q4 		$4.43K Buy
114
+14
+14% +$815 ﹤0.01% 3399
2024
Q3 		$7.56K Buy
+100
New +$8.8K ﹤0.01% 3056

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Steward Partners Investment Advisory's AEON Position: Q2 2026 in Review

Steward Partners Investment Advisory held its AEON Biopharma (AEON) position steady in Q2 2026 at 1,100 shares worth $791. The position accounts for ﹤0.01% of the portfolio, ranked #4416.

Steward Partners Investment Advisory first reported a position in AEON in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.56K in Q3 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Steward Partners Investment Advisory held 1,100 shares of AEON Biopharma worth $791 as of Q2 2026.
  • Steward Partners Investment Advisory left its AEON Biopharma share count unchanged in Q2 2026.
  • AEON Biopharma made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4416 holding.
  • Steward Partners Investment Advisory first reported a position in AEON Biopharma in Q3 2024 and has held it in 8 quarters since.
  • Steward Partners Investment Advisory's AEON Biopharma position peaked at $7.56K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.